Article
Clinical heterogeneity in patients with m.4412G > A MT-TM mutation and different heteroplasmy levels.
Mitochondrion - 1 Jul 2021
Imai-Okazaki Atsuko, Yagi Nobuyasu, Nitta Kazuhiro R, Murayama Kei, Ohtake Akira, Okazaki Yasushi
Abstract excerpt
The identification of the m.4412G > A MT-TM (mt-tRNAMet) mutation was first reported in 2019. The affected individual presented with childhood-onset seizures and myopathy and bilateral basal ganglia changes, with heteroplasmy levels in muscle as high as 90%. Here, we describe another adult-onset patient with the same mutation and additional phenotypes, including hearing impairment, cerebellar ataxia, progressive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
